XML 48 R66.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Net Income Per Share (Reconciliation Of The Numerator And Denominator Of Basic And Diluted Income Per Share) (Details) (USD $)
In Thousands, except Per Share data
3 Months Ended 6 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
Jun. 30, 2010
Net Income Per Share        
Net Income Attributable to Endo Pharmaceuticals Holding Inc., Common Stockholders $ 54,583 $ 51,460 $ 110,370 $ 111,815
For basic per share data - weighted average shares 116,663 116,060 116,509 116,704
Dilutive effect of common stock equivalents 2,434 600 2,352 642
Dilutive effect of 1.75% Convertible Senior Subordinated Notes and warrants $ 3,589   $ 2,863  
For diluted per share data - weighted average shares 122,686 116,660 121,724 117,346
Basic net income per share attributable to Endo Pharmaceuticals Holdings Inc. $ 0.47 $ 0.44 $ 0.95 $ 0.96
Diluted net income per share attributable to Endo Pharmaceuticals Holdings Inc. $ 0.44 $ 0.44 $ 0.91 $ 0.95